Canadian Drugs

Toronto (Bhreau): U.S. tariffs on pharmaceuticals will likely drive up costs and cause shortages of critical Canadian-made drugs, including antibiotics, antidepressants and HIV treatment, according to a new study.Published Monday in The Journal of the American Medical Association, the effort was led by University of Toronto drug policy researcher Mina Tadrous. Tariffs could disrupt access to essential drugs in the U.S., especially drugs where the Canadian is the only or the most commonly used product,” said Tadrous, who is also a licensed pharmacist. “This is across the board for treatments for infections and chronic diseases.”Some medications that are sole sourced…